Change in platelet indices in patients with Coronavirus disease‐2019 (COVID‐19): A reflection of platelet activation and contribution to immunothrombosis?
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY(2021)
摘要
In December 2019, several cases of pneumonia of unknown aetiology were reported in Wuhan, China. The causative Coronavirus was subsequently isolated and named the Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) and the disease, Coronavirus disease-2019 (COVID-19). COVID-19 related coagulopathy is a poor prognostic feature and reflects an underlying pathological process termed immunothrombosis. This process differs from infection-related disseminated intravascular coagulation (DIC) as it manifests primarily with thrombosis while thrombocytopenia and bleeding remain modest. The coagulation activation in COVID-19 relates to endothelial dysfunction, complement activation and ensuing cytokine storm with contributions from secondary infections and organ dysfunction. D-dimer values above 0.5 mg/L signifies poor patient outcomes.
更多查看译文
关键词
COVID-19, immunothrombosis, laboratory parameters, platelets
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要